TY  - GEN
AU  - Whitworth,Pat
AU  - Beitsch,Peter
AU  - Mislowsky,Angela
AU  - Pellicane,James V
AU  - Nash,Charles
AU  - Murray,Mary
AU  - Lee,Laura A
AU  - Dul,Carrie L
AU  - Rotkis,Michael
AU  - Baron,Paul
AU  - Stork-Sloots,Lisette
AU  - de Snoo,Femke A
AU  - Beatty,Jennifer
TI  - Chemosensitivity and Endocrine Sensitivity in Clinical Luminal Breast Cancer Patients in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) Predicted by Molecular Subtyping
SN  - 1534-4681
PY  - 2018///0223
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Anastrozole
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Aromatase Inhibitors
KW  - Breast Neoplasms
KW  - classification
KW  - Bridged-Ring Compounds
KW  - administration & dosage
KW  - Chemotherapy, Adjuvant
KW  - Clinical Decision-Making
KW  - Cyclophosphamide
KW  - Docetaxel
KW  - Doxorubicin
KW  - Female
KW  - Gene Expression Profiling
KW  - Humans
KW  - Immunohistochemistry
KW  - In Situ Hybridization, Fluorescence
KW  - Letrozole
KW  - Mastectomy, Segmental
KW  - Middle Aged
KW  - Molecular Typing
KW  - methods
KW  - Neoadjuvant Therapy
KW  - Nitriles
KW  - Prospective Studies
KW  - Receptor, ErbB-2
KW  - metabolism
KW  - Receptors, Estrogen
KW  - Receptors, Progesterone
KW  - Registries
KW  - Tamoxifen
KW  - Taxoids
KW  - Treatment Outcome
KW  - Triazoles
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase IV; Comparative Study; Journal Article; Multicenter Study
UR  - https://doi.org/10.1245/s10434-016-5600-x
ER  -